Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Medical Devices & Consumables > Global Peripheral Drug Eluting Stent Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Peripheral Drug Eluting Stent Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Peripheral Drug Eluting Stent Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Medical Devices & Consumables

Published: 2026-03-11

Pages: 98 Pages

Report ld: 6193566

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global Peripheral Drug Eluting Stent market size was US$ 6133 million in 2025 and is forecast to reach a readjusted size of US$ 10040 million by 2032 with a CAGR of 7.4% during the forecast period 2026-2032.

Peripheral Drug Eluting Stent is a kind of medical device used to treat peripheral vascular stenosis or occlusive disease. It consists of a stent, usually made of metal, and a drug coating. The stent is inserted by balloon expansion or self-expansion to support narrow or blocked blood vessels and keep blood flow open. The drug coating is coated on the surface of the stent and contains drugs that inhibit the proliferation of vascular smooth muscle cells, such as paclitaxel or sirolimus, etc., which can be released slowly after stent implantation, reducing the risk of restenosis and thrombosis in the stent, and improving the long-term patency rate of blood vessels.

Peripheral Drug Eluting Stent Market Size(US$)

M= millions and B=billions

QYRLogo
In 2025, the North America Peripheral Drug Eluting Stent market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.

Major global manufacturers of Peripheral Drug Eluting Stent include Boston Scientific, Medtronic, Abbot, W. L. Gore & Associates, iVascular SLU, Meril Life Sciences, Stentys SA, Cordis, Cook Medical, MicroPort Endovascular MedTech, among others. In 2025, the top five players accounted for approximately % of global market revenue.

In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.

The global Peripheral Drug Eluting Stent market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Global Peripheral Drug Eluting Stent Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

  • Forecasted Market Size in 2032

  • US$ 10040 million

  • CAGR(2026-2032)

  • 7.4%

  • Market Size Available for Years

  • 2026-2032

  • Global Peripheral Drug Eluting Stent Companies Covered

  • Boston Scientific

    Medtronic

    Abbot

    W. L. Gore & Associates

    iVascular SLU

    Meril Life Sciences

    Stentys SA

    Cordis

    Cook Medical

    MicroPort Endovascular MedTech

    Advanced Medical Technologies

    LifeTech Scientific Corporation

  • Global Peripheral Drug Eluting Stent Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Peripheral Drug Eluting Stent Market, Segment by Type

  • Metal Alloy Stent

    Biodegradable Stent

  • Global Peripheral Drug Eluting Stent Market, Segment by Application

  • Hospitals

    Mobile Surgery Center

    Others

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Peripheral Drug Eluting Stent sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Peripheral Drug Eluting Stent manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Peripheral Drug Eluting Stent product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Peripheral Drug Eluting Stent value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

Table of Contents

1 Market Overview
    1.1 Peripheral Drug Eluting Stent Product Scope
    1.2 Peripheral Drug Eluting Stent by Type
        1.2.1 Global Peripheral Drug Eluting Stent Sales by Type (2021, 2025 & 2032)
        1.2.2 Metal Alloy Stent
        1.2.3 Biodegradable Stent
    1.3 Peripheral Drug Eluting Stent by Application
        1.3.1 Global Peripheral Drug Eluting Stent Sales Comparison by Application (2021, 2025 & 2032)
        1.3.2 Hospitals
        1.3.3 Mobile Surgery Center
        1.3.4 Others
    1.4 Global Peripheral Drug Eluting Stent Market Estimates and Forecasts (2021-2032)
        1.4.1 Global Peripheral Drug Eluting Stent Market Size (Value) and Growth Rate (2021-2032)
        1.4.2 Global Peripheral Drug Eluting Stent Market Size (Volume) and Growth Rate (2021-2032)
        1.4.3 Global Peripheral Drug Eluting Stent Price Trends (2021-2032)
    1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
    2.1 Global Peripheral Drug Eluting Stent Market Size by Region: 2021 VS 2025 VS 2032
    2.2 Global Peripheral Drug Eluting Stent Historical Market Scenario by Region (2021-2026)
        2.2.1 Global Peripheral Drug Eluting Stent Sales Market Share by Region (2021-2026)
        2.2.2 Global Peripheral Drug Eluting Stent Revenue Market Share by Region (2021-2026)
    2.3 Global Peripheral Drug Eluting Stent Market Estimates and Forecasts by Region (2027-2032)
        2.3.1 Global Peripheral Drug Eluting Stent Sales Estimates and Forecasts by Region (2027-2032)
        2.3.2 Global Peripheral Drug Eluting Stent Revenue Forecast by Region (2027-2032)
    2.4 Major Regions and Emerging Market Analysis
        2.4.1 North America Peripheral Drug Eluting Stent Market Size and Prospects (2021-2032)
        2.4.2 Europe Peripheral Drug Eluting Stent Market Size and Prospects (2021-2032)
        2.4.3 China Peripheral Drug Eluting Stent Market Size and Prospects (2021-2032)
        2.4.4 Japan Peripheral Drug Eluting Stent Market Size and Prospects (2021-2032)
3 Global Market Size by Type
    3.1 Global Peripheral Drug Eluting Stent Historical Market Review by Type (2021-2026)
        3.1.1 Global Peripheral Drug Eluting Stent Sales by Type (2021-2026)
        3.1.2 Global Peripheral Drug Eluting Stent Revenue by Type (2021-2026)
        3.1.3 Global Peripheral Drug Eluting Stent Average Price by Type (2021-2026)
    3.2 Global Peripheral Drug Eluting Stent Market Estimates and Forecasts by Type (2027-2032)
        3.2.1 Global Peripheral Drug Eluting Stent Sales Forecast by Type (2027-2032)
        3.2.2 Global Peripheral Drug Eluting Stent Revenue Forecast by Type (2027-2032)
        3.2.3 Global Peripheral Drug Eluting Stent Price Forecast by Type (2027-2032)
    3.3 Representative Players for Different Types of Peripheral Drug Eluting Stent
4 Global Market Size by Application
    4.1 Global Peripheral Drug Eluting Stent Historical Market Review by Application (2021-2026)
        4.1.1 Global Peripheral Drug Eluting Stent Sales by Application (2021-2026)
        4.1.2 Global Peripheral Drug Eluting Stent Revenue by Application (2021-2026)
        4.1.3 Global Peripheral Drug Eluting Stent Average Price by Application (2021-2026)
    4.2 Global Peripheral Drug Eluting Stent Market Estimates and Forecasts by Application (2027-2032)
        4.2.1 Global Peripheral Drug Eluting Stent Sales Forecast by Application (2027-2032)
        4.2.2 Global Peripheral Drug Eluting Stent Revenue Forecast by Application (2027-2032)
        4.2.3 Global Peripheral Drug Eluting Stent Price Forecast by Application (2027-2032)
    4.3 New Sources of Growth in Peripheral Drug Eluting Stent Applications
5 Competition Landscape by Players
    5.1 Global Peripheral Drug Eluting Stent Sales by Player (2021-2026)
    5.2 Global Top Peripheral Drug Eluting Stent Players by Revenue (2021-2026)
    5.3 Global Peripheral Drug Eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Peripheral Drug Eluting Stent revenue as of 2025
    5.4 Global Peripheral Drug Eluting Stent Average Price by Company (2021-2026)
    5.5 Global Key Manufacturers of Peripheral Drug Eluting Stent, Manufacturing Sites & Headquarters
    5.6 Global Key Manufacturers of Peripheral Drug Eluting Stent, Product Type & Application
    5.7 Global Key Manufacturers of Peripheral Drug Eluting Stent, Date of Entry into This Industry
    5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
    6.1 North America Market: Players, Segments, Downstream and Major Customers
        6.1.1 North America Peripheral Drug Eluting Stent Sales by Company
            6.1.1.1 North America Peripheral Drug Eluting Stent Sales by Company (2021-2026)
            6.1.1.2 North America Peripheral Drug Eluting Stent Revenue by Company (2021-2026)
        6.1.2 North America Peripheral Drug Eluting Stent Sales Breakdown by Type (2021-2026)
        6.1.3 North America Peripheral Drug Eluting Stent Sales Breakdown by Application (2021-2026)
        6.1.4 North America Peripheral Drug Eluting Stent Major Customers
        6.1.5 North America Market Trends and Opportunities
    6.2 Europe Market: Players, Segments, Downstream and Major Customers
        6.2.1 Europe Peripheral Drug Eluting Stent Sales by Company
            6.2.1.1 Europe Peripheral Drug Eluting Stent Sales by Company (2021-2026)
            6.2.1.2 Europe Peripheral Drug Eluting Stent Revenue by Company (2021-2026)
        6.2.2 Europe Peripheral Drug Eluting Stent Sales Breakdown by Type (2021-2026)
        6.2.3 Europe Peripheral Drug Eluting Stent Sales Breakdown by Application (2021-2026)
        6.2.4 Europe Peripheral Drug Eluting Stent Major Customers
        6.2.5 Europe Market Trends and Opportunities
    6.3 China Market: Players, Segments, Downstream and Major Customers
        6.3.1 China Peripheral Drug Eluting Stent Sales by Company
            6.3.1.1 China Peripheral Drug Eluting Stent Sales by Company (2021-2026)
            6.3.1.2 China Peripheral Drug Eluting Stent Revenue by Company (2021-2026)
        6.3.2 China Peripheral Drug Eluting Stent Sales Breakdown by Type (2021-2026)
        6.3.3 China Peripheral Drug Eluting Stent Sales Breakdown by Application (2021-2026)
        6.3.4 China Peripheral Drug Eluting Stent Major Customers
        6.3.5 China Market Trends and Opportunities
    6.4 Japan Market: Players, Segments, Downstream and Major Customers
        6.4.1 Japan Peripheral Drug Eluting Stent Sales by Company
            6.4.1.1 Japan Peripheral Drug Eluting Stent Sales by Company (2021-2026)
            6.4.1.2 Japan Peripheral Drug Eluting Stent Revenue by Company (2021-2026)
        6.4.2 Japan Peripheral Drug Eluting Stent Sales Breakdown by Type (2021-2026)
        6.4.3 Japan Peripheral Drug Eluting Stent Sales Breakdown by Application (2021-2026)
        6.4.4 Japan Peripheral Drug Eluting Stent Major Customers
        6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
    7.1 Boston Scientific
        7.1.1 Boston Scientific Company Information
        7.1.2 Boston Scientific Business Overview
        7.1.3 Boston Scientific Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
        7.1.4 Boston Scientific Peripheral Drug Eluting Stent Products Offered
        7.1.5 Boston Scientific Recent Development
    7.2 Medtronic
        7.2.1 Medtronic Company Information
        7.2.2 Medtronic Business Overview
        7.2.3 Medtronic Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
        7.2.4 Medtronic Peripheral Drug Eluting Stent Products Offered
        7.2.5 Medtronic Recent Development
    7.3 Abbot
        7.3.1 Abbot Company Information
        7.3.2 Abbot Business Overview
        7.3.3 Abbot Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
        7.3.4 Abbot Peripheral Drug Eluting Stent Products Offered
        7.3.5 Abbot Recent Development
    7.4 W. L. Gore & Associates
        7.4.1 W. L. Gore & Associates Company Information
        7.4.2 W. L. Gore & Associates Business Overview
        7.4.3 W. L. Gore & Associates Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
        7.4.4 W. L. Gore & Associates Peripheral Drug Eluting Stent Products Offered
        7.4.5 W. L. Gore & Associates Recent Development
    7.5 iVascular SLU
        7.5.1 iVascular SLU Company Information
        7.5.2 iVascular SLU Business Overview
        7.5.3 iVascular SLU Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
        7.5.4 iVascular SLU Peripheral Drug Eluting Stent Products Offered
        7.5.5 iVascular SLU Recent Development
    7.6 Meril Life Sciences
        7.6.1 Meril Life Sciences Company Information
        7.6.2 Meril Life Sciences Business Overview
        7.6.3 Meril Life Sciences Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
        7.6.4 Meril Life Sciences Peripheral Drug Eluting Stent Products Offered
        7.6.5 Meril Life Sciences Recent Development
    7.7 Stentys SA
        7.7.1 Stentys SA Company Information
        7.7.2 Stentys SA Business Overview
        7.7.3 Stentys SA Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
        7.7.4 Stentys SA Peripheral Drug Eluting Stent Products Offered
        7.7.5 Stentys SA Recent Development
    7.8 Cordis
        7.8.1 Cordis Company Information
        7.8.2 Cordis Business Overview
        7.8.3 Cordis Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
        7.8.4 Cordis Peripheral Drug Eluting Stent Products Offered
        7.8.5 Cordis Recent Development
    7.9 Cook Medical
        7.9.1 Cook Medical Company Information
        7.9.2 Cook Medical Business Overview
        7.9.3 Cook Medical Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
        7.9.4 Cook Medical Peripheral Drug Eluting Stent Products Offered
        7.9.5 Cook Medical Recent Development
    7.10 MicroPort Endovascular MedTech
        7.10.1 MicroPort Endovascular MedTech Company Information
        7.10.2 MicroPort Endovascular MedTech Business Overview
        7.10.3 MicroPort Endovascular MedTech Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
        7.10.4 MicroPort Endovascular MedTech Peripheral Drug Eluting Stent Products Offered
        7.10.5 MicroPort Endovascular MedTech Recent Development
    7.11 Advanced Medical Technologies
        7.11.1 Advanced Medical Technologies Company Information
        7.11.2 Advanced Medical Technologies Business Overview
        7.11.3 Advanced Medical Technologies Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
        7.11.4 Advanced Medical Technologies Peripheral Drug Eluting Stent Products Offered
        7.11.5 Advanced Medical Technologies Recent Development
    7.12 LifeTech Scientific Corporation
        7.12.1 LifeTech Scientific Corporation Company Information
        7.12.2 LifeTech Scientific Corporation Business Overview
        7.12.3 LifeTech Scientific Corporation Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
        7.12.4 LifeTech Scientific Corporation Peripheral Drug Eluting Stent Products Offered
        7.12.5 LifeTech Scientific Corporation Recent Development
8 Peripheral Drug Eluting Stent Manufacturing Cost Analysis
    8.1 Peripheral Drug Eluting Stent Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Key Suppliers of Raw Materials
    8.2 Manufacturing Cost Structure
    8.3 Manufacturing Process Analysis of Peripheral Drug Eluting Stent
    8.4 Peripheral Drug Eluting Stent Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
    9.1 Marketing Channels
    9.2 Peripheral Drug Eluting Stent Distributors List
    9.3 Peripheral Drug Eluting Stent Customers
10 Peripheral Drug Eluting Stent Market Dynamics
    10.1 Peripheral Drug Eluting Stent Industry Trends
    10.2 Peripheral Drug Eluting Stent Market Drivers
    10.3 Peripheral Drug Eluting Stent Market Challenges
    10.4 Peripheral Drug Eluting Stent Market Restraints
11 Research Findings and Conclusion
12 Appendix
    12.1 Research Methodology
        12.1.1 Methodology/Research Approach
            12.1.1.1 Research Programs/Design
            12.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        12.1.2 Data Source
            12.1.2.1 Secondary Sources
            12.1.2.2 Primary Sources
    12.2 Author Details
    12.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Peripheral Drug Eluting Stent Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)
 Table 2. Global Peripheral Drug Eluting Stent Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
 Table 3. Global Market Peripheral Drug Eluting Stent Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
 Table 4. Global Peripheral Drug Eluting Stent Sales (K Units) by Region (2021-2026)
 Table 5. Global Peripheral Drug Eluting Stent Sales Market Share by Region (2021-2026)
 Table 6. Global Peripheral Drug Eluting Stent Revenue (US$ Million) Market Share by Region (2021-2026)
 Table 7. Global Peripheral Drug Eluting Stent Revenue Share by Region (2021-2026)
 Table 8. Global Peripheral Drug Eluting Stent Sales (K Units) Forecast by Region (2027-2032)
 Table 9. Global Peripheral Drug Eluting Stent Sales Market Share Forecast by Region (2027-2032)
 Table 10. Global Peripheral Drug Eluting Stent Revenue (US$ Million) Forecast by Region (2027-2032)
 Table 11. Global Peripheral Drug Eluting Stent Revenue Share Forecast by Region (2027-2032)
 Table 12. Global Peripheral Drug Eluting Stent Sales by Type (K Units) & (2021-2026)
 Table 13. Global Peripheral Drug Eluting Stent Sales Share by Type (2021-2026)
 Table 14. Global Peripheral Drug Eluting Stent Revenue by Type (US$ Million) & (2021-2026)
 Table 15. Global Peripheral Drug Eluting Stent Average Price by Type (US$/Unit) & (2021-2026)
 Table 16. Global Peripheral Drug Eluting Stent Sales by Type (K Units) & (2027-2032)
 Table 17. Global Peripheral Drug Eluting Stent Revenue by Type (US$ Million) & (2027-2032)
 Table 18. Global Peripheral Drug Eluting Stent Average Price by Type (US$/Unit) & (2027-2032)
 Table 19. Representative Players of Each Type
 Table 20. Global Peripheral Drug Eluting Stent Sales by Application (K Units) & (2021-2026)
 Table 21. Global Peripheral Drug Eluting Stent Sales Share by Application (2021-2026)
 Table 22. Global Peripheral Drug Eluting Stent Revenue by Application (US$ Million) & (2021-2026)
 Table 23. Global Peripheral Drug Eluting Stent Average Price by Application (US$/Unit) & (2021-2026)
 Table 24. Global Peripheral Drug Eluting Stent Sales by Application (K Units) & (2027-2032)
 Table 25. Global Peripheral Drug Eluting Stent Revenue Market Share by Application (US$ Million) & (2027-2032)
 Table 26. Global Peripheral Drug Eluting Stent Average Price by Application (US$/Unit) & (2027-2032)
 Table 27. New Sources of Growth in Peripheral Drug Eluting Stent Applications
 Table 28. Global Peripheral Drug Eluting Stent Sales by Company (K Units) & (2021-2026)
 Table 29. Global Peripheral Drug Eluting Stent Sales Share by Company (2021-2026)
 Table 30. Global Peripheral Drug Eluting Stent Revenue by Company (US$ Million) & (2021-2026)
 Table 31. Global Peripheral Drug Eluting Stent Revenue Share by Company (2021-2026)
 Table 32. Global Peripheral Drug Eluting Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Drug Eluting Stent as of 2025)
 Table 33. Global Market Peripheral Drug Eluting Stent Average Price by Company (US$/Unit) & (2021-2026)
 Table 34. Global Key Manufacturers of Peripheral Drug Eluting Stent, Manufacturing Sites & Headquarters
 Table 35. Global Key Manufacturers of Peripheral Drug Eluting Stent, Product Type & Application
 Table 36. Global Key Manufacturers of Peripheral Drug Eluting Stent, Date of Entry into This Industry
 Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 38. North America Peripheral Drug Eluting Stent Sales by Company (2021-2026) & (K Units)
 Table 39. North America Peripheral Drug Eluting Stent Sales Market Share by Company (2021-2026)
 Table 40. North America Peripheral Drug Eluting Stent Revenue by Company (2021-2026) & (US$ Million)
 Table 41. North America Peripheral Drug Eluting Stent Revenue Market Share by Company (2021-2026)
 Table 42. North America Peripheral Drug Eluting Stent Sales by Type (2021-2026) & (K Units)
 Table 43. North America Peripheral Drug Eluting Stent Sales Market Share by Type (2021-2026)
 Table 44. North America Peripheral Drug Eluting Stent Sales by Application (2021-2026) & (K Units)
 Table 45. North America Peripheral Drug Eluting Stent Sales Market Share by Application (2021-2026)
 Table 46. Europe Peripheral Drug Eluting Stent Sales by Company (2021-2026) & (K Units)
 Table 47. Europe Peripheral Drug Eluting Stent Sales Market Share by Company (2021-2026)
 Table 48. Europe Peripheral Drug Eluting Stent Revenue by Company (2021-2026) & (US$ Million)
 Table 49. Europe Peripheral Drug Eluting Stent Revenue Market Share by Company (2021-2026)
 Table 50. Europe Peripheral Drug Eluting Stent Sales by Type (2021-2026) & (K Units)
 Table 51. Europe Peripheral Drug Eluting Stent Sales Market Share by Type (2021-2026)
 Table 52. Europe Peripheral Drug Eluting Stent Sales by Application (2021-2026) & (K Units)
 Table 53. Europe Peripheral Drug Eluting Stent Sales Market Share by Application (2021-2026)
 Table 54. China Peripheral Drug Eluting Stent Sales by Company (2021-2026) & (K Units)
 Table 55. China Peripheral Drug Eluting Stent Sales Market Share by Company (2021-2026)
 Table 56. China Peripheral Drug Eluting Stent Revenue by Company (2021-2026) & (US$ Million)
 Table 57. China Peripheral Drug Eluting Stent Revenue Market Share by Company (2021-2026)
 Table 58. China Peripheral Drug Eluting Stent Sales by Type (2021-2026) & (K Units)
 Table 59. China Peripheral Drug Eluting Stent Sales Market Share by Type (2021-2026)
 Table 60. China Peripheral Drug Eluting Stent Sales by Application (2021-2026) & (K Units)
 Table 61. China Peripheral Drug Eluting Stent Sales Market Share by Application (2021-2026)
 Table 62. Japan Peripheral Drug Eluting Stent Sales by Company (2021-2026) & (K Units)
 Table 63. Japan Peripheral Drug Eluting Stent Sales Market Share by Company (2021-2026)
 Table 64. Japan Peripheral Drug Eluting Stent Revenue by Company (2021-2026) & (US$ Million)
 Table 65. Japan Peripheral Drug Eluting Stent Revenue Market Share by Company (2021-2026)
 Table 66. Japan Peripheral Drug Eluting Stent Sales by Type (2021-2026) & (K Units)
 Table 67. Japan Peripheral Drug Eluting Stent Sales Market Share by Type (2021-2026)
 Table 68. Japan Peripheral Drug Eluting Stent Sales by Application (2021-2026) & (K Units)
 Table 69. Japan Peripheral Drug Eluting Stent Sales Market Share by Application (2021-2026)
 Table 70. Boston Scientific Company Information
 Table 71. Boston Scientific Description and Business Overview
 Table 72. Boston Scientific Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 73. Boston Scientific Peripheral Drug Eluting Stent Product
 Table 74. Boston Scientific Recent Development
 Table 75. Medtronic Company Information
 Table 76. Medtronic Description and Business Overview
 Table 77. Medtronic Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 78. Medtronic Peripheral Drug Eluting Stent Product
 Table 79. Medtronic Recent Development
 Table 80. Abbot Company Information
 Table 81. Abbot Description and Business Overview
 Table 82. Abbot Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 83. Abbot Peripheral Drug Eluting Stent Product
 Table 84. Abbot Recent Development
 Table 85. W. L. Gore & Associates Company Information
 Table 86. W. L. Gore & Associates Description and Business Overview
 Table 87. W. L. Gore & Associates Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 88. W. L. Gore & Associates Peripheral Drug Eluting Stent Product
 Table 89. W. L. Gore & Associates Recent Development
 Table 90. iVascular SLU Company Information
 Table 91. iVascular SLU Description and Business Overview
 Table 92. iVascular SLU Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 93. iVascular SLU Peripheral Drug Eluting Stent Product
 Table 94. iVascular SLU Recent Development
 Table 95. Meril Life Sciences Company Information
 Table 96. Meril Life Sciences Description and Business Overview
 Table 97. Meril Life Sciences Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 98. Meril Life Sciences Peripheral Drug Eluting Stent Product
 Table 99. Meril Life Sciences Recent Development
 Table 100. Stentys SA Company Information
 Table 101. Stentys SA Description and Business Overview
 Table 102. Stentys SA Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 103. Stentys SA Peripheral Drug Eluting Stent Product
 Table 104. Stentys SA Recent Development
 Table 105. Cordis Company Information
 Table 106. Cordis Description and Business Overview
 Table 107. Cordis Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 108. Cordis Peripheral Drug Eluting Stent Product
 Table 109. Cordis Recent Development
 Table 110. Cook Medical Company Information
 Table 111. Cook Medical Description and Business Overview
 Table 112. Cook Medical Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 113. Cook Medical Peripheral Drug Eluting Stent Product
 Table 114. Cook Medical Recent Development
 Table 115. MicroPort Endovascular MedTech Company Information
 Table 116. MicroPort Endovascular MedTech Description and Business Overview
 Table 117. MicroPort Endovascular MedTech Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 118. MicroPort Endovascular MedTech Peripheral Drug Eluting Stent Product
 Table 119. MicroPort Endovascular MedTech Recent Development
 Table 120. Advanced Medical Technologies Company Information
 Table 121. Advanced Medical Technologies Description and Business Overview
 Table 122. Advanced Medical Technologies Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 123. Advanced Medical Technologies Peripheral Drug Eluting Stent Product
 Table 124. Advanced Medical Technologies Recent Development
 Table 125. LifeTech Scientific Corporation Company Information
 Table 126. LifeTech Scientific Corporation Description and Business Overview
 Table 127. LifeTech Scientific Corporation Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 128. LifeTech Scientific Corporation Peripheral Drug Eluting Stent Product
 Table 129. LifeTech Scientific Corporation Recent Development
 Table 130. Production Base and Market Concentration Rate of Raw Material
 Table 131. Key Suppliers of Raw Materials
 Table 132. Peripheral Drug Eluting Stent Distributors List
 Table 133. Peripheral Drug Eluting Stent Customers List
 Table 134. Peripheral Drug Eluting Stent Market Trends
 Table 135. Peripheral Drug Eluting Stent Market Drivers
 Table 136. Peripheral Drug Eluting Stent Market Challenges
 Table 137. Peripheral Drug Eluting Stent Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources


List of Figures
 Figure 1. Peripheral Drug Eluting Stent Product Picture
 Figure 2. Global Peripheral Drug Eluting Stent Sales (US$ Million) by Type (2021, 2025 & 2032)
 Figure 3. Global Peripheral Drug Eluting Stent Sales Market Share by Type in 2025 & 2032
 Figure 4. Metal Alloy Stent Product Picture
 Figure 5. Biodegradable Stent Product Picture
 Figure 6. Global Peripheral Drug Eluting Stent Sales (US$ Million) by Application (2021, 2025 & 2032)
 Figure 7. Global Peripheral Drug Eluting Stent Sales Market Share by Application in 2025 & 2032
 Figure 8. Hospitals Examples
 Figure 9. Mobile Surgery Center Examples
 Figure 10. Others Examples
 Figure 11. Global Peripheral Drug Eluting Stent Sales, (US$ Million), 2021 VS 2025 VS 2032
 Figure 12. Global Peripheral Drug Eluting Stent Sales Growth Rate (2021-2032) & (US$ Million)
 Figure 13. Global Peripheral Drug Eluting Stent Sales (K Units) Growth Rate (2021-2032)
 Figure 14. Global Peripheral Drug Eluting Stent Price Trends Growth Rate (2021-2032) & (US$/Unit)
 Figure 15. Peripheral Drug Eluting Stent Report Years Considered
 Figure 16. Global Market Peripheral Drug Eluting Stent Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
 Figure 17. Global Peripheral Drug Eluting Stent Revenue Market Share by Region: 2021 VS 2025
 Figure 18. North America Peripheral Drug Eluting Stent Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 19. North America Peripheral Drug Eluting Stent Sales (K Units) Growth Rate (2021-2032)
 Figure 20. Europe Peripheral Drug Eluting Stent Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 21. Europe Peripheral Drug Eluting Stent Sales (K Units) Growth Rate (2021-2032)
 Figure 22. China Peripheral Drug Eluting Stent Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 23. China Peripheral Drug Eluting Stent Sales (K Units) Growth Rate (2021-2032)
 Figure 24. Japan Peripheral Drug Eluting Stent Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 25. Japan Peripheral Drug Eluting Stent Sales (K Units) Growth Rate (2021-2032)
 Figure 26. Global Peripheral Drug Eluting Stent Revenue Share by Type (2021-2026)
 Figure 27. Global Peripheral Drug Eluting Stent Sales Share by Type (2027-2032)
 Figure 28. Global Peripheral Drug Eluting Stent Revenue Share by Type (2027-2032)
 Figure 29. Global Peripheral Drug Eluting Stent Revenue Share by Application (2021-2026)
 Figure 30. Global Peripheral Drug Eluting Stent Revenue Market Share by Application in 2021 & 2025
 Figure 31. Global Peripheral Drug Eluting Stent Sales Share by Application (2027-2032)
 Figure 32. Global Peripheral Drug Eluting Stent Revenue Share by Application (2027-2032)
 Figure 33. Global Peripheral Drug Eluting Stent Sales Share by Company (2025)
 Figure 34. Global Peripheral Drug Eluting Stent Revenue Share by Company (2025)
 Figure 35. Global 5 Largest Peripheral Drug Eluting Stent Players Market Share by Revenue in Peripheral Drug Eluting Stent: 2021 & 2025
 Figure 36. Peripheral Drug Eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
 Figure 37. Manufacturing Cost Structure of Peripheral Drug Eluting Stent
 Figure 38. Manufacturing Process Analysis of Peripheral Drug Eluting Stent
 Figure 39. Peripheral Drug Eluting Stent Industrial Chain
 Figure 40. Channels of Distribution (Direct Vs Distribution)
 Figure 41. Distributors Profiles
 Figure 42. Bottom-up and Top-down Approaches for This Report
 Figure 43. Data Triangulation
 Figure 44. Key Executives Interviewed

Description 

The global Peripheral Drug Eluting Stent market size was US$ 6133 million in 2025 and is forecast to reach a readjusted size of US$ 10040 million by 2032 with a CAGR of 7.4% during the forecast period 2026-2032.

Peripheral Drug Eluting Stent is a kind of medical device used to treat peripheral vascular stenosis or occlusive disease. It consists of a stent, usually made of metal, and a drug coating. The stent is inserted by balloon expansion or self-expansion to support narrow or blocked blood vessels and keep blood flow open. The drug coating is coated on the surface of the stent and contains drugs that inhibit the proliferation of vascular smooth muscle cells, such as paclitaxel or sirolimus, etc., which can be released slowly after stent implantation, reducing the risk of restenosis and thrombosis in the stent, and improving the long-term patency rate of blood vessels.
In 2025, the North America Peripheral Drug Eluting Stent market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.

Major global manufacturers of Peripheral Drug Eluting Stent include Boston Scientific, Medtronic, Abbot, W. L. Gore & Associates, iVascular SLU, Meril Life Sciences, Stentys SA, Cordis, Cook Medical, MicroPort Endovascular MedTech, among others. In 2025, the top five players accounted for approximately % of global market revenue.

In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.

The global Peripheral Drug Eluting Stent market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.

Market Segmentation
Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Peripheral Drug Eluting Stent sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Peripheral Drug Eluting Stent manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Peripheral Drug Eluting Stent product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Peripheral Drug Eluting Stent value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
den_biaoTiZhungShi

Related Reports

Global Peripheral Drug Eluting Stent Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Medical Devices & Consumables

Published: 2026-03-11

Pages: 98 Pages

Report ld: 6193566

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 4250.00

tip

USD 6375.00

tip

USD 8500.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now